Two scientists at the University of Washington lay out how U.S. cuts to science research funding are expected to have a resounding public health…
The Alzheimer’s Association’s latest “Facts and Figures” report finds most Americans want early screening and access to disease-modifying drugs — even at high cost…
From clinical trials to funding cuts: Here’s how changes at NIH are reshaping Alzheimer’s and dementia research. As of September 2024, 495 clinical trials…
You’ve likely encountered Red Dye #3 before. It’s a common additive to many candies, beverages, baked goods, cereals, maraschino cherries and gelatin desserts, as…
A Trump executive order has banned DEI initiatives across the federal government. Scientists say the move could undermine trial diversity and derail the quest…
When Eisai announced in a press release this week that they’d secured FDA approval for an Alzheimer’s drug dosage change, it seemed like a…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
This month, the U.S. Senate passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024. Originally signed into law in…
“No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden,” Maria Shriver and George Vradenburg wrote…
Climate change is making the symptoms of certain brain conditions worse, our new review has found. Conditions that can worsen as temperature and humidity…
“Hi Christy, it’s Tori at [media outlet]/interview request.”* The email continued: Reaching out to see whether you can join our morning show. There’s been…
More than 38 million Americans have diabetes, 16.8 million of them over the age of 65. In addition to increasing the risk of heart…
Wildfires, gasoline, oil, and wood fuels release plumes of pollutants that negatively impact lung and brain health. Most of these health risks come from…
Diagnosed with Alzheimer’s and one of the relative few who has gotten a prescription for the new, disease-modifying anti-amyloid drug Leqembi? If you live…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Caribbean neuroscientist Indira Turney’s research is centered…